Prostate Cancer Profile II (Serial Monitor)
Use
Monitor the course of prostate cancer, patient response to treatment, and disease recurrence
Special Instructions
It is essential that the patient's Social Security number is submitted for monitoring purposes. When conducting serial testing, it is imperative to maintain consistency with one assay method, as variations in methods cannot be used interchangeably.
Limitations
The results obtained from different assay methods or kits should not be used interchangeably due to variability in test methodologies. Additionally, these test results should not be interpreted as conclusive evidence of the presence or absence of malignant disease.
Methodology
Immunoassay (ECLIA)
Biomarkers
LOINC Codes
- 20420-6
- 2857-1
- 80563-0
Result Turnaround Time
2-4 days
Related Documents
For more information, please review the documents below
Specimen
Serum
Volume
1 mL
Minimum Volume
0.5 mL
Container
Red-top tube or gel-barrier tube. Do not use acid phosphatase transport tube.
Storage Instructions
Refrigerated and frozen
Causes for Rejection
Plasma or whole blood specimen; hemolysis; frozen sample not received for PAP